Philanthropic funding to fight HIV/AIDS reached the highest level to date—$680 million—according to the 15th annual report from the Funders Concerned About AIDS (FCAA). The report, titled Philanthropic Support to Address HIV/AIDS in 2016, was released shortly after World AIDS Day 2017 and covers data from the last calendar year. (Click on the image above to watch a video about the report.)
Most of the funding went to research and prevention. Despite the third straight year of increases, there is reason for concern, notes the FCAA in a press release for the report. That’s because the uptick was the result of more funding from a select few donors, while the majority of groups showed a decrease in funding.
“Once again, the majority of philanthropic resources allocated to fighting the epidemic is concentrated among a handful of donors,” said FCAA’s executive director, John Barnes, in the press release. “The top 20 funders accounted for 87 percent of 2016 resources. In fact, without the two largest funders—Gates Foundation and Gilead Sciences, which, together, represent over half of all funding in 2016—total giving to HIV/AIDS among all other private funders decreased 5 percent.”
The FCAA notes that its key findings include:
Key findings from the 2016 report include:
- For the third year in a row, HIV/AIDS philanthropic funding to the United States reached a new high, totaling $175 million
- Funding to low- and middle-income countries increased by 11 percent from 2015 to 2016
- The top regional recipient outside of North America was East & Southern Africa
- The top intended use for funding was research (which, at $249 million, increased 13 percent from 2015) followed by prevention (a 26 percent increase at $169 million)
- Commitments to advocacy and human rights increased by 1 percent, bringing the total level of resources allocated to this critical issue to a new high of $125 million
- Funding for all key populations decreased from 2015 to 2016.
You can read and download the report here. It includes many more graphics like the one above.